News

Research shows that it is almost universally optimal for men to begin androgen deprivation therapy to reduce testosterone levels when starting radiation, rather than before.

Disrupted circadian rhythms have been identified as a probable carcinogen, and in a new study, researchers have described how a disrupted circadian clock can enhance lung tumor growth.

Researchers have tested a new treatment for pancreatic cancer in mice and report that tumors were completely eliminated in 80% of mice across several model types.

A research team plans to use genetic information from a patient's tumor to guide radiotherapy doses, based on mutations that drive radiotherapy sensitivity.

A new study has shown that endothelial cells – the cells that line blood vessels – can become corrupted when grown alongside leukemia cells and rescue the cancer cells from chemotherapy drugs.

Researchers have developed a strategy to noninvasively track macrophages within brain and breast tumors in living mice.

Two drugs that inhibit precancerous cell progression have been shown to reverse a process that precedes pancreatic cancer, hopefully enabling earlier treatment for the disease.

Researchers have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme.

Researchers have investigated what drives the growth of advanced prostate cancer tumors that have become resistant to standard therapy. Working with cells and animal models, they discovered an approach that suppresses the growth of resistant tumors.

Researchers have developed a new approach to delivering immunotherapy agents directly to cells in the tumor microenvironment, using an acid-seeking molecule called pHLIP®.